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ABSTRACT
Preterm birth remains the leading cause ofperinatal mortality and morbidity. Evidence suggests that
intrauterine infection plays an important role in the pathogenesis of preterm labor. This article
reviews the clinical data supporting this theory and the cellular and biochemical mechanisms by
which intrauterine infection may initiate uterine contractions. The clinical and laboratory methods
of diagnosing clinical chorioamnionitis and asymptomatic bacterial invasion of the intraamniotic
cavity are also reviewed. Finally, the management of clinical chorioamnionitis and asymptomatic
microbial invasion of the amniotic fluid and the use of adjunctive antibiotic therapy in the treatment
ofpreterm labor are presented. (C) 1995 Wiley-Liss, Inc.
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Preterm birth remains the leading cause of perina-
tal mortality and morbidity. Eighty-three percent
of" the neonatal mortality in nonanomalous infants
occurs in infants born before the 37th week of
gestation. Premature infants who survive the per-
inatal period experience significant morbidity in-
cluding respiratory distress, intraventricular hem-
orrhage, sepsis, necrotizing enterocolitis, and patent
ductus arteriosus.
2 Despite the well-recognized
risks of preterm birth and concerted efforts to suc-
cessfully arrest preterm labor, the incidence of pre-
term delivery has not decreased over the past de-
cade, remaining at 9.6%.
3
Recent research focusing on the pathogenesis of
preterm labor suggests that intrauterine infection
may play an important role in preterm labor and
delivery. This article reviews the clinical, cellular,
and biochemical data that support this theory, as
well as the clinical and laboratory methods of diag-
nosing clinical chorioamnionitis and asymptomatic
bacterial invasion of the intraamniotic cavity. Fi-
nally, the management issues regarding the treat-
ment and role of adjunctive antibiotic therapy in
preterm labor are presented.
The term "intrauterine infection" includes both
clinical and asymptomatic microbial invasion of the
amniotic cavity. For the purpose of this review
"histologic chorioamnionitis" is defined as histo-
logic inflammation of the amnion and chorion and
"clinical chorioamnionitis" is reserved for the clin-
ical syndrome associated with microbial invasion of
the intraamniotic cavity.
INTRAUTERINE INFECTION AND
PRETERM DELIVERY
Clinical Evidence
A review of 15 studies in which amniocenteses were
performed on women in preterm labor with intact
membranes reveals the rate of microbial invasion of
the amniotic cavity to be 12.2%.
4-18 The bacterial
isolation rates range from 0 to 48%, depending on
the study population and culture technique. Al-
though most of these women had no signs or symp-
toms of infection at the time of presentation, they
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were more likely to develop clinical chorioamnion-
itis. Furthermore, women in preterm labor with
positive cultures were more likely to be refractory
to tocolytics and to have spontaneous premature
rupture of the membranes (PROM) and a shorter
interval from presentation to delivery. This evi-
dence indirectly supports the role of infection in the
pathogenesis of preterm labor with intact mem-
branes. Alternatively, these data could be inter-
preted to suggest that women with preterm labor
are at increased risk for microbial invasion of the
amniotic cavity.
PROM accounts for up to one-third of all pre-
term deliveries. Seven studies have examined the
rate of intrauterine infection by performing trans-
abdominal amniocentesis on women with
PROM.
19-25 Transabdominal amniocenteses were
successfully performed on 59% of these women,
28% ofwhom had positive amniotic fluid cultures.
The rate of microbial invasion of the amniotic cav-
ity in the women with unsuccessful amniocenteses is
unknown but theoretically higher than 28%, as
women withPROM and oligohydramnios are more
likely to develop chorioamnionitis23’26 but less
likely to have a successful amniocentesis due to
technical di’’iculty.
19-25 Therefore, these studies
support the association of intrauterine infection and
PROM, although a causal relationship has not been
clearly established. One study documented a higher
incidence of positive cultures in women who pre-
sented with PROM and preterm labor (39%) com-
pared with women with PROM alone (25%).
25
Eighty-one of 160 women with negative cultures
who were not in labor at the time of admission
subsequently developed preterm labor. Of these 81
women, 48 had repeat amniocenteses at the onset of
labor, and 7 5% had positive cultures at that time.
25
This suggests that intrauterine infection may play a
pivotal role in the onset of preterm labor associated
with PROM.
Preterm delivery is associated with an increased
rate of postpartum endometritis and early neonatal
sepsis,
27-29 which provides further circumstantial
evidence to support intrauterine infection as an eti-
ological factor in preterm labor and delivery.
The pathologic examination of the placenta and
membranes revealed an increased rate of histologic
chorioamnionitis following premature delivery (up
to 60%) compared with the rate following term
delivery (up to 20%).3’1 As histologic chorioam-
nionitis is correlated with positive amniotic-fluid
cultures, the hypothesis is that intrauterine infec-
tion, with resulting inflammation of the placental
membranes, stimulates the onset of preterm labor.
The pathogenesis of intrauterine infection ap-
pears to be related to ascending pathogens. An asso-
ciation between genitourinary colonization with
group B streptococcus2’3 and Neisserisa gonor-
rhoeae
4-6 and premature delivery has been estab-
lished. In addition, the eradication of these patho-
gens with antibiotics has significantly decreased the
preterm delivery rate.37’8 Bacterial vaginosis and
cervicovaginal colonization with Bacteroidesfragilis
have also been associated with preterm delivery,
although their eradication has yet to demonstrate a
significant benefit. 1,39-44 The role of cervicovag-
inal Chlamydia trachomatis, Ureaplasma urealyti-
cum, and Trichomonas vaginalis on prematurity is
less well established.
Biochemical Mechanisms
Prostaglandins have been implicated in the initia-
tion of labor at term. This theory is supported by
the observations that 1) prostaglandins and their
precursor, arachidonic acid, stimulate abortion and
labor;
4s 2) amniotic-fluid levels of prostaglandins
and arachidonic acid increase during labor;
46-49
and 3) prostaglandin inhibitors arrest preterm con-
50--52 tractions and delay the onset of labor at term.
The role of prostaglandins in the onset of preterm
labor is less well defined. However, women with
preterm labor and microbial invasion of the amni-
otic cavity have higher amniotic fluid levels of
PGE2 and PGF2, than women with preterm labor
and negative amniotic-fluid cultures or women
without preterm labor, s-58 The sources of these
prostaglandins are postulated to be the amnion,
chorion, and decidua, s9-6 Indeed, media from
bacterial cultures stimulate PGE2 and PGF2, pro-
duction from isolated human amnion and decidual
cells.
62-65 Therefore, prostaglandins appear to play
an important role in preterm labor in the presence
of infection.
Prostaglandin production from placental mem-
branes and decidual cells increases directly in re-
sponse to bacterial products such as phospholipase Az
and phospholipase C. These stimulate the release of
arachidonic acid from the membrane phospholip-
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ids, phosphatidylinositol and phosphatidylethanol-
amine.
66-68 Endotoxin, or lipopolysaccharide, a com-
ponent of the cell wall of gram-negative bacteria,
stimulates prostaglandin production by the amnion
and decidua69’7 and is increased in the amniotic fluid
of women with microbial invasion of the amniotic
cavity
71 or PROM and labor.
72 However, the
amount of endotoxin found in the amniotic cavity in
women with PROM and labor
72 is lower than that
required to stimulate prostaglandin production by the
amnion.
69 Therefore, it has been postulated that an
amplification of the host response by endotoxin stim-
ulates the production of inflammatory mediators.
Endotoxin stimulates the production of inflam-
matory mediators, cytokines or monokines, from
macrophages.
73-76 The 3 cytokines that have been
extensively investigated in relation to preterm labor
and intrauterine infection are interleukin-1, inter-
leukin-6, and tumor-necrosis factor. These cyto-
kines stimulate the production of prostaglandins by
the amnion, chorion, decidua, and myometrium in
vitro.73,75,77--81 The amniotic-fluid levels of inter-
leukin-1, interleukin-6, and tumor-necrosis factor
are higher in women with microbial invasion of the
amniotic cavity and preterm labor compared with
the levels in women with microbial invasion of the
amniotic cavity who are not in labor or women
without microbial invasion of the amniotic cav-
ity. 73’75’77-81 Elevated cytokine levels are also as-
sociated with increased amniotic-fluid levels of pros-
taglandins and unsuccessful tocolysis. 75’82-84
Finally, the systemic administration of interleu-
kin-1 in mice induces preterm delivery,
85 which
can be inhibited by the administration of a natural
interleukin-1 receptor antagonist.
86 The amniotic-
fluid levels of interleukin-1 receptor antagonist are
reduced in women with intraamniotic-fluid infec-
tion and preterm labor despite elevated levels of
interleukin- 1.87
The sum of these data suggests that microbial
invasion of the amniotic cavity results in a release of
bacterial endotoxin which stimulates cytokine pro-
duction and results in arachidonic-acid metabolism,
prostaglandin production, and the onset of labor.
However, the simultaneous or sequential produc-
tion of several cytokines may be necessary to stimu-
late this cascade through a positive feedback mech-
anism88’89 or a prolonged exposure to elevated
levels of cytokines may be necessary, as individual
cytokines do not acutely stimulate myometrial con-
tractile activity in vitro.
9
DIAGNOSIS OF INTRAUTERINE INFECTION
A diagnosis of clinical chorioamnionitis is based
upon fever >37.8C; rupture ofmembranes; and 2
or more of the following criteria: maternal or fetal
tachycardia, uterine tenderness, malodorous amni-
otic fluid, or peripheral leukocytosis with no other
site of infection.
91,92
The gold standard for the diagnosis of subclini-
cal intrauterine infection has been the amniotic-
fluid culture. Because the results are usually not
obtainable for 48-72 h, several techniques for the
rapid identification of microbial invasion of the
amniotic cavity have been investigated.
A Gram’s stain of the amniotic fluid is a simple
and inexpensive test to perform. Numerous reports
have shown it to have a sensitivity of about 49.5%
(140/283 patients) and a specificity of 97.7% (888/
909 patients) when compared with the amniotic-
fluid culture in the setting of preterm labor with
intact membranes or PROM.4,s,8,11,13,16,19--
22,24,93--97 The low sensitivity of the Gram’s stain
to detect microbial invasion of the amniotic cavity
is probably related to its inability to demonstrate
mycoplasmas which are among the most common
isolates in asymptomatic microbial invasion of the
amniotic cavity.
97
Low amniotic-fluid glucose levels have been in-
vestigated as a rapid, simple, and inexpensive indi-
cator of microbial invasion of the amniotic cavity.
With a cutoff level of < 14-16 mg/dl, this tech-
nique has been found to have a sensitivity of 33-
92% and a specificity of 58-94% in women with
preterm labor or PROM when compared with
amniotic-fluid cultures.
94-98 Due to the wide vari-
ation in sensitivity and specificity, the clinical
utility of amniotic-fluid glucose levels in identify-
ing microbial invasion of the amniotic cavity is
low.
An amniotic-fluid white blood cell (WBC) count
of > 5 0 cells/mm has been shown to have a sensi-
tivity of 64% and specificity of 94% when com-
pared with amniotic-fluid culture for identifying
microbial invasion of the amniotic cavity in women
with preterm labor and intact membranes.
97 The
amniotic-fluidWBC count may be useful in women
with asymptomatic microbial invasion of the amni-
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otic fluid, but otherwise has little clinical value.
The leukocyte esterase assay of amniotic fluid (a
measure of leukocyte activity) was shown to have a
higher sensitivity (81%) in one study,
99 but this
report has not been confirmed.
9
A laboratory technique, currently unavailable
for clinical use in most centers, is the determination
ofamniotic-fluid interleukin-6 levels. Elevated am-
niotic-fluid interleukin-6 levels have been found to
be more predictive of microbial invasion of the
amniotic cavity, amniocentesis-to-delivery interval,
and neonatal complications than the Gram’s stain,
glucose concentration, or WBC count in women
with preterm labor and intact membranes and in
women with PROM. 96’97’10 However, there are
no studies documenting a benefit from intervention
in the setting of preterm labor or PROM with
elevated cytokine levels. Therefore, the clinical rel-
evance of these reports is uncertain.
MANAGEMENT
Clinical Chorioamnionitis
Once the diagnosis of clinical chorioamnionitis has
been made, antibiotic therapy should be instituted.
Prompt intrapartum treatment clearly decreases the
rate of neonatal and maternal morbidity.
101 As
chorioamnionitis is a polymicrobial infection, the
combination therapy of ampicillin and gentamicin
is effective.
101-1 o3 Single-agent therapy using sec-
ond- or third-generation cephalosporins or ex-
tended-spectrum penicillins has not been studied in
large randomized trials. A critical diagnosis-to-de-
livery interval has not been determined; however,
there are little data on the outcome in patients who
deliver > 12 h after diagnosis. It has been recom-
mended that clindamycin be added to the antibiotic
regimen if the patient is delivered by cesarean in an
attempt to decrease the severity of postpartum en-
dometritis, although little data exist to support this
recommendation.
91
Asymptomatic Microbial Invasion of the
Amniotic Fluid
While the early identification of microbial invasion
of the amniotic cavity raises the possibility of many
innovative therapeutic options, such as antibiotics
without prompt delivery or anticytokines, these op-
tions have not been investigated. Many patients
with preterm labor and microbial invasion of the
amniotic cavity are refractory to tocolysis, and
women with PROM and microbial invasion of the
amniotic cavity have shorter latency periods. The
management of a patient with preterm labor or
PROM who has a positive amniotic-fluid culture
without clinical chorioamnionitis has not been ad-
dressed in the literature. In our clinical practice,
we do not routinely perform an amniocentesis for
an amniotic-fluid culture in a woman with preterm
labor or a woman with PROM. However, we
recommend an amniotic-fluid culture in the case of
refractory preterm labor. In this situation, we ini-
tiate antibiotic therapy and proceed toward delivery
if the amniotic-fluid culture is positive. Due to the
paucity of data in this area, these management deci-
sions should be individualized.
Adjunctive Antibiotic Therapy in
Preterm Labor
The large body of evidence that supports an etio-
logic role of infection in preterm labor has
prompted several investigations of adjuvant antibi-
otics for women with preterm labor. To date, the
reported results have been contradictory. McGre-
gor et al.
104 randomized 17 patients to a [3-sym-
pathomimetic agent plus placebo or [3-sympatho-
mimetic agent plus erythromycin and found a
statistically significant increase in the number of
women who delivered at term in the erythromycin-
treated group. Morales et al.
ls randomized 150
women with "idiopathic preterm labor" to ampicil-
lin, erythromycin, or no treatment. They found a
statistically significant prolongation of pregnancy
in the antibiotic-treated groups; however, the ad-
ministration of a placebo was not included in the
study design, a wide range was noted in the number
of days of prolongation of gestation, and no signif-
icant improvement was shown in the proportion of
pregnancies reaching 37 weeks gestation. McGre-
gor et al.
106 reported a prolongation of pregnancy
(3 5 vs. 25 days) in 103 women receiving tocolytics
for preterm labor who were randomized to receive
clindamycin or placebo.
In contrast to these 3 studies, Newton et al.
found no difference in the prolongation of preg-
nancy or outcome in 78 women randomized to
receive either ampicillin plus erythromycin or pla-
cebo in conjunction with standard tocolytics. They
reported similar results in 86 patients receiving
magnesium-sulfate tocolysis who were randomized
to receive ampicillin-sulbactam plus indomethacin
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or placebo.
18 Recently, in a multicenter double-
blind, placebo-controlled trial, 277 women on to-
colytic therapy for preterm labor were randomized
to receive either ampicillin plus erythromycin or
placebo.
109 No difference was found in the rate of
preterm delivery, clinical chorioamnionitis, endo-
metritis, or neonatal outcome. In this study, only
5.8% of the 239 women who had amniocenteses
had positive amniotic-fluid cultures.
Basic and clinical evidence supports the etiologic
role of infection in some cases of preterm labor.
Intrauterine infection is often present in women
with preterm labor or PROM, and bacterial prod-
ucts such as endotoxin and cytokines stimulate pros-
taglandin production. These data suggest a role for
antibiotics in the prevention of preterm birth. As
preterm labor is probably multifactorial,
11 it is
unlikely that adjunctive antibiotic therapy will be
of any therapeutic benefit in those women in whom
infection is not present. Clearly, there is a need for
a large randomized placebo-controlled study on the
effect of adjunctive antibiotic therapy in women in
preterm labor and intact membranes with asymp-
tomatic microbial invasion of the amniotic cavity.
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